Low-dose naltrexone holds great promise for the millions of people worldwide with autoimmune diseases or central nervous system disorders or who face a deadly cancer. In the developing world, LDN could provide the first low-cost, easy to administer, and side-effect-free therapy for HIV/AIDS....